Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model

Japanese Journal of Cancer Research

Volumn 88, Issue 3, 1997, Pages 245-253

  Murai, Takashi ^a,b   Mori, Satoru ^a,b   Hosono, Motoko ^b   Takashima, Akira ^b   Machino, Setsuko ^b   Oohara, Tadao ^b   Yamashita, Hirofumi ^b   Makino, Susumu ^b   Matsuda, Tsutomu ^a   Wanibuchi, Hideki ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

ODS Shi od od rat; Sodium L ascorbate; Urinary bladder carcinogenesis; WS Shi rat; (2u) globulin

Indexed keywords

ALPHA 2U GLOBULIN; ASCORBIC ACID; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER TUMOR; CANCER MODEL; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; TUMOR PROMOTION; URINALYSIS;

EID: 0030966039     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00374.x     Document Type: Article

References (42)

1. Kaisary, A., Smith, P., Jaczq, E., McAllister, B., Wilkinson, G. R., Ray, W. A. and Branch, R. A. Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res., 47, 5488-5493 (1987).
2. Silverberg, E. Statistical and epidemiologic data on urologic cancer. Cancer, 60, 692-717 (1987).
3. Ito, N., Arai, M., Sugihara, S., Hirao, K., Makiura, S., Matayoshi, K. and Denda, A. Experimental urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann Monogr. Cancer Res., 17, 367-381 (1975).
4. Ito, N. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Cancer Res., 36, 2528-2531 (1976).
5. Mori, S., Takeuchi, Y., Toyama, M., Makino, S., Harauchi, T., Kurata, Y. and Fukushima, S. Assessment of L-ascorbic acid requirement for prolonged survival in ODS rats and their susceptibility to urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett., 38, 275-282 (1988).
6. Nakanowatari, J., Fukushima, S., Imaida, K., Ito, N. and Nagase, S. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats. Jpn. J. Cancer Res. (Gann), 79, 453-459 (1988).
7. Fukushima, S., Arai, M., Nakanowatari, J., Hibino, T., Okuda, M. and Ito, N. Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. Gann, 74, 8-20 (1983).
8. Takahashi, M., Shumiya, S., Maekawa, A., Hayashi, Y. and Nagase, S. High susceptibility of an analbuminemic congenic strain of rats with an F344 genetic background to induced bladder cancer and its possible mechanism. Jpn. J. Cancer Res. (Gann), 79, 705-709 (1988).
9. Suzuki, E., Anjo, T., Aoki, J. and Okada, M. Species variations in the metabolism of N-butyl-N-(4-hydroxy- butyl)nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Gann, 74, 60-68 (1983).
10. Garland, E. M., St. John, M., Asamoto, M., Eklund, S. H., Mattson, B. J., Johnson, L. S., Cano, M. and Cohen, S. M. A comparison of the effects of sodium saccharin in NBR rats and in intact and castrated male F344 rats. Cancer Lett., 78, 99-107 (1994).
11. Chappel, C. I. A review and biological risk assessment of sodium saccharin. Regul. Toxicol. Pharmacol., 15, 253-270 (1992).
12. Hicks, R. M. Multistage carcinogenesis in the urinary bladder. Br. Med. Bull., 36, 39-46 (1980).
13. Ito, N. and Fukushima, S. Promotion of urinary bladder carcinogenesis in experimental animals. Exp. Pathol., 36, 1-15 (1989).
14. Mori, S., Murai, T., Takeuchi, Y., Hosono, M., Ohhara, T., Makino, S., Hayashi,Y., Shibata, M.-A., Kurata, Y., Hagiwara, A. and Fukushima, S. No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability. Carcinogenesis, 12, 1869-1873 (1991).
15. Horio, F., Ozaki, K., Yoshida, A., Makino, S. and Hayashi, Y. Ascorbic acid requirement in a rat mutant unable to synthesize ascorbic acid. J. Nutr., 115, 1630-1640 (1985).
16. Horio, F., Ozaki, K., Kohmura, M., Yoshida, A., Makino, S. and Hayashi, Y. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid. J. Nutr., 116, 2278-2289 (1986).
17. Makino, S., Yamashita, H., Harada, M., Konishi, T. and Hayashi, Y. Genetic monitoring of the ODS rat. In "Vitamin C and the Scurvy-Prone ODS Rat," ed. T. Fujita, M. Fukase and T. Konishi, pp. 29-34 (1982). Elsevier, Amsterdam.
18. Mori, S., Kurata, Y., Takeuchi, Y., Toyama, M., Makino, S. and Fukushima, S. Influences of strain and diet on the promoting effects of sodium L-ascorbate in two-stage urinary bladder carcinogenesis in rats. Cancer Res., 47, 3492-3495 (1987).
19. Cohen, S. M., Cano, M., Earl, R. A., Carson, S. D. and Garland, E. M. A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium. Carcinogenesis, 12, 1551-1555 (1991).
20. Hard, G. C. Species comparison of the content and composition of urinary proteins. Food Chem. Toxicol., 33, 731-746 (1995).
21. Uwagawa, S., Saito, K., Okuno, Y., Kawasaki, H., Yoshitake, A., Yamada, H. and Fukushima, S. Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-Black-Reiter (NBR) male rats. Toxicol. Appl. Pharmacol., 127, 182-186 (1994).
22. Saito, K., Uwagawa, S., Kaneko, H. and Yoshitake, A. Behavior of alpha-2u-globulin accumulation in kidneys of male rats treated with d-limonene: kidney-type alpha-2u-globulin in the urine as a marker of d-limonene nephropathy. Toxicology, 79, 173-183 (1991).
23. Roe, J. H. and Kuether, C. A. The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J. Biol. Chem., 147, 399-407 (1943).
24. Fukushima, S., Murasaki, G., Hirose, M., Nakanishi, K., Hasegawa, R. and Ito, N. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol. Jpn., 32, 243-250 (1982).
25. Rao, G. N., Edmondson, J. and Elwell, M. R. Influence of dietary protein concentration on severity of nephropathy in Fischer-344 (F-344/N) rats. Toxicol. Pathol., 21, 353-361 (1993).
26. Matsuda, T., Imaoka, S., Funae, Y., Otori, K. and Fukushima, S. Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or β-naphthoflavone. Cancer Lett., 97, 137-143 (1995).
27. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685 (1970).
28. Scheffe, H. A. "The Analysis of Variance" (1959), Wiley, New York.
29. Dunn, O. J. Multiple comparisons among means. J. Am. Stat. Assoc., 56, 52-64 (1961).
30. Asamoto, M., Tsuda, H., Kagawa, M., de Camargo, J. L. V., Ito, N. and Nagase, S. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: quantitation of glutathione 5-transferase P-posi- live foci development. Jpn. J. Cancer Res., 80, 939-944 (1989).
31. Asamoto, M., Tsuda, H., Kato, T., Ito, N., Masuko, T., Hashimoto, Y. and Nagase, S. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-acetylaminofluorene and phenobarbital. Jpn. J. Cancer Res., 80, 1041-1046 (1989).
32. Fukushima, S., Shibata, M.-A., Shirai, T., Tamano, S. and Ito, N. Role of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats. Cancer Res., 46, 1623-1626 (1986).
33. Otoshi, T., Iwata, H., Yamamoto, S., Murai, T., Yamaguchi, S., Matsui-Yuasa, I., Otani, S. and Fukushima, S. Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH. Carcinogenesis, 14, 2277-2281 (1993).
34. Cohen, S. M., Arai, M., Jacobs, J. B. and Friedell, G. H. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res., 39, 1207-1217 (1979).
35. Fukushima, S., Kurata, Y., Shibata, M.-A., Ikawa, E. and Ito, N. Promoting effect of sodium O-phenylphenate and O-phenylphenol on two-stage urinary bladder carcinogenesis in rats. Gann, 74, 625-632 (1983).
36. Fukushima, S., Imaida, K., Sakata, T., Okamura, T., Shibata, M.-A. and Ito, N. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res., 43, 4454-4457 (1983).
37. Fukushima, S., Kurata, Y., Shibata, M.-A., Ikawa, E. and Ito, N. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett., 23, 29-37 (1984).
38. Fukushima, S., Thamavit, W., Kurata, Y. and Ito, N. Sodium citrate: a promoter of bladder carcinogenesis. Jpn. J. Cancer Res. (Gann), 77, 1-4 (1986).
39. + exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature, 304, 645-648 (1983).
40. L'Allemain, G., Paris, S. and Pouyssegur, J. Growth factor action and intracellular pH regulation in fibroblasts. J. Biol. Chem., 259, 5809-5815 (1984).
41. + transport by rabbit urinary bladder. J. Membr. Biol., 28, 41-70 (1976).
42. Hotta, K., Yamamoto, Y., Imaida, K., Oshima, M., Fukushima, S. and Ito, N. Membrane potential of rat urinary epithelial cells. Jpn. J. Physiol., 33, 139-143 (1983).